Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2025 -1.917
September 30, 2025 -2.142
June 30, 2025 -2.272
March 31, 2025 -2.475
December 31, 2024 -2.864
September 30, 2024 -3.558
June 30, 2024 -3.175
March 31, 2024 -3.747
December 31, 2023 -2.815
September 30, 2023 -3.832
June 30, 2023 -5.916
March 31, 2023 -11.62
December 31, 2022 -33.18
September 30, 2022 8.731
June 30, 2022 3.639
March 31, 2022 -12.16
December 31, 2021 -310.84
September 30, 2021 102.67
June 30, 2021 -167.72
March 31, 2021 -661.77
December 31, 2020 -45.71
September 30, 2020 11.75
June 30, 2020 -116.44
March 31, 2020 107.01
December 31, 2019 21.68
Date Value
September 30, 2019 2.103
June 30, 2019 2.093
March 31, 2019 2.285
December 31, 2018 1.869
September 30, 2018 1.212
June 30, 2018 1.432
March 31, 2018 1.447
December 31, 2017 1.439
September 30, 2017 0.8959
June 30, 2017 0.8913
March 31, 2017 0.8736
December 31, 2016 0.8875
September 30, 2016 0.4817
June 30, 2016 0.471
March 31, 2016 0.471
December 31, 2015 0.434
September 30, 2015 0.4695
June 30, 2015 0.5322
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00
September 30, 2013 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
DBV Technologies SA 0.0784
Cellectis SA 2.539
Akari Therapeutics Plc 0.0373
Autolus Therapeutics Plc 4.915
Evaxion AS 0.7455

Debt to Equity Ratio Related Metrics